Interleukin-12 in Treating Patients With Cancer in the Abdomen

ABSTRACT: RATIONALE: Interleukin-12 may kill tumor cells by stimulating a person’s white blood cells to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-12 in treating patients with cancer in the abdomen.

DISEASE(S): Gallbladder Neoplasms,Colorectal Cancer,Gastric Cancer,Colorectal Neoplasms,Pancreatic Cancer,Anal Cancer,Gallbladder Cancer,Pancreatic Neoplasms,Stomach Neoplasms,Anus Neoplasms

PROVIDER: 2002634 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR